UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Immunocompatibility and biocompatibility of cell delivery systems

Advanced drug delivery reviews, 2000-08, Vol.42 (1), p.65-80

Rihova, Blanka

2000

Volltextzugriff (PDF)

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties

Journal of controlled release, 2001-05, Vol.73 (1), p.89-102

2001

Volltextzugriff (PDF)

Immunomodulating activities of soluble synthetic polymer-bound drugs

Advanced drug delivery reviews, 2002-09, Vol.54 (5), p.653-674

Rihova, Blanka

2002

Volltextzugriff (PDF)

HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity

Journal of controlled release, 2012-12, Vol.164 (3), p.346-354

2012

Volltextzugriff (PDF)

Biodegradable star HPMA polymer–drug conjugates: Biodegradability, distribution and anti-tumor efficacy

Journal of controlled release, 2011-09, Vol.154 (3), p.241-248

2011

Volltextzugriff (PDF)

Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours

European journal of pharmaceutical sciences, 2014-07, Vol.58, p.1-12

2014

Volltextzugriff (PDF)

HPMA Copolymer Conjugates of Paclitaxel and Docetaxel with pH-Controlled Drug Release

Molecular pharmaceutics, 2010-08, Vol.7 (4), p.1015-1026

2010

Volltextzugriff (PDF)

Immunogenicity and immunomodulatory properties of HPMA-based polymers

Advanced drug delivery reviews, 2010-02, Vol.62 (2), p.184-191

2010

Volltextzugriff (PDF)

Receptor-mediated targeted drug or toxin delivery

Advanced drug delivery reviews, 1998-02, Vol.29 (3), p.273-289

Rihova, Blanka

1998

Volltextzugriff (PDF)

Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer–Doxorubicin Drug Conjugates with pH-Triggered Drug Release

Molecular pharmaceutics, 2018-09, Vol.15 (9), p.3654-3663

2018

Volltextzugriff (PDF)

Simultaneous Delivery of Doxorubicin and Protease Inhibitor Derivative to Solid Tumors via Star-Shaped Polymer Nanomedicines Overcomes P‑gp- and STAT3-Mediated Chemoresistance

Biomacromolecules, 2022-06, Vol.23 (6), p.2522-2535

2022

Volltextzugriff (PDF)

Polymer nanomedicines based on micelle-forming amphiphilic or water-soluble polymer-doxorubicin conjugates: Comparative study of in vitro and in vivo properties related to the polymer carrier structure, composition, and hydrodynamic properties

Journal of controlled release, 2020-05, Vol.321, p.718-733

2020

Volltextzugriff (PDF)

Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester

Journal of controlled release, 2013-01, Vol.165 (2), p.153-161

2013

Volltextzugriff (PDF)

Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting

Journal of controlled release, 2008-12, Vol.132 (3), p.184-192

2008

Volltextzugriff (PDF)

The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel

Journal of controlled release, 2017-01, Vol.246, p.1-11

2017

Volltextzugriff (PDF)

HPMA Copolymer Conjugates of DOX and Mitomycin C for Combination Therapy: Physicochemical Characterization, Cytotoxic Effects, Combination Index Analysis, and Anti-Tumor Efficacy

Macromolecular bioscience, 2013-12, Vol.13 (12), p.1648-1660

2013

Volltextzugriff (PDF)

N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation

Journal of applied polymer science, 2008-09, Vol.109 (5), p.3050-3061

2008

Volltextzugriff (PDF)

Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy

Journal of controlled release, 2007-09, Vol.122 (1), p.31-38

2007

Volltextzugriff (PDF)

HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy

Pharmaceutics, 2021-01, Vol.13 (2), p.179

2021

Volltextzugriff (PDF)

Polymer donors of nitric oxide improve the treatment of experimental solid tumours with nanosized polymer therapeutics

Journal of drug targeting, 2017-11, Vol.25 (9-10), p.796-808

2017

Volltextzugriff (PDF)

Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation

European journal of pharmaceutics and biopharmaceutics, 2010-11, Vol.76 (3), p.514-524

2010

Volltextzugriff (PDF)

Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification

Journal of controlled release, 2006-09, Vol.115 (1), p.26-36

2006

Volltextzugriff (PDF)

HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity

Journal of controlled release, 2009-11, Vol.140 (1), p.18-26

2009

Volltextzugriff (PDF)

Novel “soft” biodegradable nanoparticles prepared from aliphatic based monomers as a potential drug delivery system

Soft matter, 2012-01, Vol.8 (16), p.4343

2012

Volltextzugriff (PDF)

In vitro and in vivo immunomodulatory effects of microdispersed oxidized cellulose

International immunopharmacology, 2002-09, Vol.2 (10), p.1429-1441

2002

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(111)

Publikationsform

Artikel
(120)

Sprache

Englisch
(120)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(73)
Animals
(58)
Mice
(48)
Physical Sciences
(45)
Pharmacology & Pharmacy
(38)
Biological And Medical Sciences
(37)
Medical Sciences
(36)
Pharmacology. Drug Treatments
(33)
Chemistry
(32)
Humans
(31)
Doxorubicin
(27)
Mice, Inbred C57bl
(27)
Chemistry, Multidisciplinary
(26)
Female
(25)
Cell Line, Tumor
(23)
General Pharmacology
(22)
Pharmaceutical Technology. Pharmaceutical Industry
(22)
Technology
(19)
Doxorubicin - Pharmacology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunocompatibility and biocompatibility of cell delivery systems

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties

Immunomodulating activities of soluble synthetic polymer-bound drugs

HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity

Biodegradable star HPMA polymer–drug conjugates: Biodegradability, distribution and anti-tumor efficacy

Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours

HPMA Copolymer Conjugates of Paclitaxel and Docetaxel with pH-Controlled Drug Release

Immunogenicity and immunomodulatory properties of HPMA-based polymers

Receptor-mediated targeted drug or toxin delivery

Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer–Doxorubicin Drug Conjugates with pH-Triggered Drug Release

Simultaneous Delivery of Doxorubicin and Protease Inhibitor Derivative to Solid Tumors via Star-Shaped Polymer Nanomedicines Overcomes P‑gp- and STAT3-Mediated Chemoresistance

Polymer nanomedicines based on micelle-forming amphiphilic or water-soluble polymer-doxorubicin conjugates: Comparative study of in vitro and in vivo properties related to the polymer carrier structure, composition, and hydrodynamic properties

Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester

Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting

The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel

HPMA Copolymer Conjugates of DOX and Mitomycin C for Combination Therapy: Physicochemical Characterization, Cytotoxic Effects, Combination Index Analysis, and Anti-Tumor Efficacy

N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation

Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy

HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy

Polymer donors of nitric oxide improve the treatment of experimental solid tumours with nanosized polymer therapeutics

Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation

Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification

HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity

Novel “soft” biodegradable nanoparticles prepared from aliphatic based monomers as a potential drug delivery system

In vitro and in vivo immunomodulatory effects of microdispersed oxidized cellulose

Suchergebnisse filtern